Mission Statement

The Tugela Ferry Care and Research Collaboration (TF CARES) is an international non-governmental organization committed to improving prevention, care, and treatment for adults and children with HIV/AIDS and tuberculosis through clinical care, research and capacity building in Tugela Ferry, South Africa.

NIH Funding for Point-of-Care CD4 Analysis

TF CARES is proud to announce that our partners, Yale University in New Haven, Connecticut and Philanjalo NGO in Tugela Ferry, South Africa, have been receiving funding from the National Institutes of Health (NIH) for a project focused on Point-of-Care CD4 Analysis.  The project, currently in its second year, seeks to determine whether use of fingerstick CD4 analysis is feasible in community-based settings, reduces delays in starting HIV care, and can be used by non-clinical personnel.  It is supported by an R21 grant from National Institute of Allergy and Infectious Disease (NIAID). Dr. Gerald Friedland (Yale University) and Dr. Sheela Shenoi are the Primary Investigators and Dr. Tony Moll (Philanjalo) is a Co-investigator.

First 18 Patients Cured through Community-Based Treatment of MDR-TB

Patients Cured

TF CARES is proud to announce that the first 18 patients enrolled in our community-based MDR-TB treatment program have been cured. An event was held on World TB Day to honor these patients and celebrate their successful conclusion of two years of treatment.

In response to overcrowded hospitals and high treatment default rates, TF CARES began community-based treatment of patients with multidrug resistant TB in 2008. Following diagnosis with MDR-TB, patients are treated in their homes by a team of nurses and community health workers who provide clinical care and treatment support. The full course of treatment is two years, including six months of daily injections.

Community-based treatment of MDR-TB is not only more cost effective than hospital-based treatment, it significantly reduces the rate of treatment default by allowing patients to stay in their homes. Patients tell us that treatment is less of a burden when they are allowed to stay with their families, in comfortable settings with emotional and social support.